These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 29993037)

  • 1. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.
    Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC
    Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of pancreatic stellate cell activation by Notch3.
    Song H; Zhang Y
    BMC Cancer; 2018 Jan; 18(1):36. PubMed ID: 29304760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting HGF/c-MET Axis in Pancreatic Cancer.
    Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.
    Higuchi T; Orita T; Katsuya K; Yamasaki Y; Akiyama K; Li H; Yamamoto T; Saito Y; Nakamura M
    Mol Cell Biol; 2004 Sep; 24(17):7456-68. PubMed ID: 15314156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.
    Nones K; Waddell N; Song S; Patch AM; Miller D; Johns A; Wu J; Kassahn KS; Wood D; Bailey P; Fink L; Manning S; Christ AN; Nourse C; Kazakoff S; Taylor D; Leonard C; Chang DK; Jones MD; Thomas M; Watson C; Pinese M; Cowley M; Rooman I; Pajic M; ; Butturini G; Malpaga A; Corbo V; Crippa S; Falconi M; Zamboni G; Castelli P; Lawlor RT; Gill AJ; Scarpa A; Pearson JV; Biankin AV; Grimmond SM
    Int J Cancer; 2014 Sep; 135(5):1110-8. PubMed ID: 24500968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).
    Li Z; Lin P; Gao C; Peng C; Liu S; Gao H; Wang B; Wang J; Niu J; Niu W
    Tumour Biol; 2016 Apr; 37(4):5117-31. PubMed ID: 26547582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.
    Cui J; Xia T; Xie D; Gao Y; Jia Z; Wei D; Wang L; Huang S; Quan M; Xie K
    Oncogene; 2016 Sep; 35(36):4708-18. PubMed ID: 26876216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.
    You N; Li J; Gong Z; Huang X; Wang W; Wang L; Wu K; Zheng L
    Mol Carcinog; 2017 Feb; 56(2):607-624. PubMed ID: 27350032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
    Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
    Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model.
    Takakura K; Shibazaki Y; Yoneyama H; Fujii M; Hashiguchi T; Ito Z; Kajihara M; Misawa T; Homma S; Ohkusa T; Koido S
    PLoS One; 2015; 10(12):e0142981. PubMed ID: 26642349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment.
    Dey S; Liu S; Factora TD; Taleb S; Riverahernandez P; Udari L; Zhong X; Wan J; Kota J
    BMC Cancer; 2020 Jul; 20(1):651. PubMed ID: 32660466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1.
    Li S; Yan G; Yue M; Kang Z; Wang L
    Mol Med Rep; 2019 Feb; 19(2):1380-1387. PubMed ID: 30569091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.
    Gomez-Chou SB; Swidnicka-Siergiejko AK; Badi N; Chavez-Tomar M; Lesinski GB; Bekaii-Saab T; Farren MR; Mace TA; Schmidt C; Liu Y; Deng D; Hwang RF; Zhou L; Moore T; Chatterjee D; Wang H; Leng X; Arlinghaus RB; Logsdon CD; Cruz-Monserrate Z
    Cancer Res; 2017 May; 77(10):2647-2660. PubMed ID: 28249896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.
    Chen CH; Wang SW; Chen CW; Huang MR; Hung JS; Huang HC; Lin HH; Chen RJ; Shyu MK; Huang MC
    Gynecol Oncol; 2013 Mar; 128(3):560-7. PubMed ID: 23262208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
    Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAG3-positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma.
    Yuan Y; Jiang JY; Wang JM; Sun J; Li C; Liu BQ; Yan J; Meng XN; Wang HQ
    J Cell Mol Med; 2019 Aug; 23(8):5006-5016. PubMed ID: 31119886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.
    Tang D; Wang D; Yuan Z; Xue X; Zhang Y; An Y; Chen J; Tu M; Lu Z; Wei J; Jiang K; Miao Y
    Int J Cancer; 2013 Mar; 132(5):993-1003. PubMed ID: 22777597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α.
    Yan B; Jiang Z; Cheng L; Chen K; Zhou C; Sun L; Qian W; Li J; Cao J; Xu Q; Ma Q; Lei J
    Exp Cell Res; 2018 Oct; 371(1):63-71. PubMed ID: 30056064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.